Home » Newsletters » BioWorld

BioWorld

Sep. 27, 1991

View Archived Issues

ANALYST DOWNPLAYS GM-CSF PATENT NEWS

CHIRON/CETUS MERGER PASSES FTC DEADLINE

CENTOCOR RAISES SIZE OF DEBENTURES

EPITOPE GETS GRANT FOR HIV TEST

MGI GETS RIGHTS TO PILOCARPINE MOUTHWASH

HEMACARE EXTENDS WARRANT EXPIRATION

OXFORD COMPLETES $8M FINANCING

SBIR GRANTED FOR AMYLIN MABS

FDA PANEL RECOMMENDATION SPURS CHIRON

SUITS OPPOSE GI MERGER WITH AHP

COMBINATION TEST APPROVED FOR HIV-1, 2

MULTIDRUG STRATEGY TO COMBAT AIDS

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...